SELL and myalgic encephalomeyelitis/chronic fatigue syndrome: At the 6th month, γδ1 T cells expression of CD62L+CD11a− was significantly reduced in severe CFS/ME compared to both controls and moderate CFS/ME (p = 0.013 and 0.023) (Fig. 8d).